FDA.reportPublic FDA data

metformin hydrochloride 1000 MG / rosiglitazone 4 MG Oral Tablet [Avandamet]

RxCUI
861765
RxNorm name
metformin hydrochloride 1000 MG / rosiglitazone 4 MG Oral Tablet [Avandamet]
Display name
metformin hydrochloride 1000 MG / rosiglitazone 4 MG Oral Tablet [Avandamet]
Full name
metformin hydrochloride 1000 MG / rosiglitazone 4 MG Oral Tablet [Avandamet]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0789dc6b-db34-44a6-8a5d-fdcc8e4ce8fdAvandamet 4 MG / 1000 MG Oral Tablet [PSN] · metformin hydrochloride 1000 MG / rosiglitazone 4 MG Oral Tablet [Avandamet] [SBD] · Avandamet 4/1000 MG Oral Tablet [SY]36These highlights do not include all the information needed to use AVANDAMET safely and effectively. See full prescribing information for AVANDAMET. AVANDAMET (rosiglitazone maleate and metformin hydrochloride) Tablets Initial U.S. Approval: 200220120830